SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer and HIV Vaccines Enter the Therapeutic Era

2.

FDA Approves Subcutaneous Isatuximab for MM Indications

3.

Cancer detection recovered following pandemic disruptions

4.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

5.

Alcohol Causes Cancer. We Should Be Drinking Less.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot